These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 37119603

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Human papillomavirus genotypic characteristics of 60,685 subjects under age-expansion vaccination of the nine-valent human papillomavirus vaccine: A cross-sectional study.
    Liu Y, Li Z, Yuan L, Liu F, Wu K, Xiao X, Zhu C.
    J Infect Public Health; 2023 Jul; 16(7):989-995. PubMed ID: 37167646
    [Abstract] [Full Text] [Related]

  • 23. Prevalent characteristics of human papillomavirus infection in 29,508 women in Jinshan District, Shanghai.
    Yu Y, Liu HL, He CF, Wang Y, Fu WJ, Gan GP, Qu HL, Zhou YN, Yao L.
    Taiwan J Obstet Gynecol; 2022 Nov; 61(6):971-976. PubMed ID: 36428000
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. HPV genotype prevalence and distribution during 2009-2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination.
    Wang J, Tang D, Wang K, Wang J, Zhang Z, Chen Y, Zhang X, Ma C.
    BMC Womens Health; 2019 Jul 08; 19(1):90. PubMed ID: 31286939
    [Abstract] [Full Text] [Related]

  • 26. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    Ndizeye Z, Vanden Broeck D, Lebelo RL, Bogers J, Benoy I, Van Geertruyden JP.
    PLoS One; 2019 Jul 08; 14(6):e0209303. PubMed ID: 31237894
    [Abstract] [Full Text] [Related]

  • 27. Prevalence and genotype distribution of human papillomavirus infection among women in Jingzhou, China: a population-based study of 51,720 women.
    Liu S, Mei B, Ouyang Y, Li C.
    Virol J; 2023 Dec 15; 20(1):297. PubMed ID: 38102627
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Analysis of the Prevalence and Quantification of viral load of different human papillomavirus types in Turkish women population.
    Tekkesın N, Goktas S, Alkis V, Koc S, Gurbuz T, Goktas P.
    Asian Pac J Cancer Prev; 2022 Dec 01; 23(12):4347-4355. PubMed ID: 36580019
    [Abstract] [Full Text] [Related]

  • 30. The distribution and pathogenic risk of non-9-valent vaccine covered HPV subtypes in cervical lesions.
    Ma M, Zhu J, Yang Y, Wang X, Jin Y, Zhang J, Wu S.
    Cancer Med; 2022 Mar 01; 11(6):1542-1552. PubMed ID: 34981653
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT, Min KJ, Cho HW, Ki M, Oh JK, Shin SY, Hong JH, Lee JK.
    J Gynecol Oncol; 2018 Jan 01; 29(1):e14. PubMed ID: 29185272
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Marembo T, Dube Mandishora R, Borok M.
    Intervirology; 2019 Jan 01; 62(2):90-95. PubMed ID: 31412350
    [Abstract] [Full Text] [Related]

  • 34. Detection of 14 High-risk Human Papillomavirus (HPV) Genotypes Within the Italian Cervical Cancer Screening.
    Cenci M, Rossi F, Pisani T.
    In Vivo; 2023 Jan 01; 37(5):2161-2165. PubMed ID: 37652482
    [Abstract] [Full Text] [Related]

  • 35. HPV prevalence and genotype distribution in 2,306 patients with cervical squamous cell carcinoma in central and eastern China.
    Han C, Huang W, Ye M, Zou R, Lan J, Chen J, Jiang J, Wang H, Xia L, Luo J, Li D, Geng J, Wang Z, Huang J.
    Front Public Health; 2023 Jan 01; 11():1225652. PubMed ID: 37701907
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, Podzolkova NM, Shipulina OY, Sultanov SN, Kosenko IA, Brotons M, Buttmann N, Dartell M, Arbyn M, Syrjänen S, Poljak M.
    Vaccine; 2013 Dec 31; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [Abstract] [Full Text] [Related]

  • 39. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
    Wang HY, Lee D, Park S, Kim G, Kim S, Han L, Yubo R, Li Y, Park KH, Lee H.
    Asian Pac J Cancer Prev; 2015 Dec 31; 16(17):7633-40. PubMed ID: 26625774
    [Abstract] [Full Text] [Related]

  • 40. Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023.
    Yao X, Li Q, Chen Y, Du Z, Huang Y, Zhou Y, Zhang J, Wang W, Zhang L, Xie J, Xu C, Ge Y, Zhou Y.
    Front Public Health; 2024 Dec 31; 12():1332696. PubMed ID: 38590815
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.